emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

First Page		Document Content
Date: 2015-07-08 04:50:21 Pharmaceuticals policy Health Pharmaceutical industry Pharmacology European Medicines Agency European Union Marketing authorization European Directorate for the Quality of Medicines EudraLex European Pharmacopoeia Orphan drug Supplementary protection certificate		emea_strap_url_cmyk_rev_en_std_cent.eps MASTER Add to Reading List Source URL: www.hma.eu Download Document from Source Website File Size: 535,20 KB Share Document on Facebook

	TIGes vet Q&A-update - Sept 2013 DocID: 1rsZK - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	CMDh meeting with representative of Interested Parties 19 May 2015  Type IA variation label implementation guidance. DocID: 1rqES - View Document
	Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \ MERGEFORMAT Annex VI: Imple DocID: 1rqtS - View Document
	Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in us DocID: 1rpxR - View Document